Cervical Cancer News and Research

RSS

Cancer is a disease in which cells in the body grow out of control. Cancer is always named for the part of the body where it starts, even if it spreads to other body parts later. When cancer starts in the cervix, it is called cervical cancer. The cervix is the lower, narrow end of the uterus. Also known as the womb, the uterus is where a baby grows when a woman is pregnant. The cervix connects the upper part of the uterus to the vagina (birth canal).

Cervical cancer is highly preventable in most Western countries because screening tests and a vaccine to prevent HPV infections are available. When cervical cancer is found early, it is highly treatable and associated with long survival and good quality of life.

Machine learning algorithm decodes mutations driving cancer treatment resistance

In a groundbreaking study published on January 18, 2024, in Cancer Discovery, scientists at University of California San Diego School of Medicine leveraged a machine learning algorithm to tackle one of the biggest challenges facing cancer researchers: predicting when cancer will resist chemotherapy.

18 Jan 2024

Study explores intratumoral microbiota as a novel frontier in cancer research

Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.

14 Jan 2024

What would a Nikki Haley presidency look like for health care?

Republican presidential hopeful Nikki Haley will learn how her campaign is resonating with voters after the Jan. 15 Iowa caucuses, the first presidential nominating contest of this election year.

12 Jan 2024

Optimizing cervical cancer screening: New study evaluates best approaches for HIV-positive women

Researchers evaluated the effectiveness and outcomes of various cervical cancer screening strategies for women living with HIV in Tanzania, supporting World Health Organisation's (WHO's) 2021 guidelines for reducing cervical cancer mortality in this high-risk group.

14 Dec 2023

Study models advantages, harms, and affordability of WHO proposed cervical cancer screening strategies for women in LMICs

The harms, benefits, and affordability of seven primary screening algorithms for human papillomavirus (HPV).

14 Dec 2023

Lymphatic fluid from surgical drains could inform more precise treatments for head and neck cancer

Lymphatic fluid from surgical drains, which is usually tossed in the trash, is a treasure in the hands of University of Pittsburgh and Washington University School of Medicine in St. Louis researchers who found that this liquid could inform more precise treatments for patients with head and neck cancer caused by human papillomavirus (HPV).

11 Dec 2023

Active surveillance for cervical precancer lesions linked to increased long-term cancer risk

Actively monitoring abnormal cells (lesions) that line the cervix rather than removing them straight away is associated with an increased long term risk of cervical cancer, suggests a study published by The BMJ today.

29 Nov 2023

HPV self-sampling kits via direct mail boost cervical cancer screening rates, study finds

Researchers examined the effectiveness of opt-in and direct-mail strategies for offering self-sampling kits of human papillomavirus (HPV) to populations based on cervical cancer screening history.

28 Nov 2023

Combined application of therapeutic viruses and nanomaterials to revolutionize cancer therapy

Using oncolytic viruses (OVs) in combination with nanomaterials as a novel approach to cancer treatment.

22 Nov 2023

Study: 1.3 million lives lost every year to cancers caused by smoking tobacco across 7 countries

Every year 1.3 million lives are lost to cancers caused by smoking tobacco across the UK, US and BRICS nations (Brazil, Russia, India, China and South Africa), according to a new study, funded by Cancer Research UK.

15 Nov 2023

An effective solution to improve visualization of the cervix during pelvic exams

Pelvic exams are an indispensable part of gynecological care and are used to screen for conditions, such as cervical cancer, that affect millions of patients every year.

14 Nov 2023

Women with disabilities have lower cervical cancer screening rates, study finds

Around 11,500 new cases of cervical cancer are diagnosed each year in the United States, according to the Centers for Disease Control (CDC). The CDC tracks cervical cancer rates by age, race, and ethnicity, but not by disability type.

30 Oct 2023

New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

25 Oct 2023

Lactobacillus iners in tumors: Driving chemoradiation resistance via lactate-induced metabolic rewiring

Investigating tumor and gut microbiome traits that impact chemoradiation therapy in patients with cervical cancer.

24 Oct 2023

Short course of induction chemotherapy can reduce cervical cancer relapse and death by 35%

The INTERLACE phase III trial, funded by Cancer Research UK and UCL Cancer Trials Centre, assessed whether a short course of induction chemotherapy (IC) prior to chemoradiation (CRT) could reduce the rate of relapse and death among patients with locally advanced cervical cancer.

22 Oct 2023

Cervical cancer rates increasing in Appalachian Kentucky

While the overall incidence and death rates from cervical cancer have dropped in the U.S., the opposite has been occurring in Appalachian Kentucky – a steady increase. The death rate from cervical cancer in Appalachian Kentucky is now twice that of the national rate.

19 Oct 2023

Lactate-producing intratumoral bacteria drive resistance to radiation therapy

Researchers at The University of Texas MD Anderson Cancer Center have discovered that lactate-producing intratumoral bacteria drives resistance to radiation therapy, suggesting that lactic acid-producing bacteria present in various cancers may serve as novel therapeutic targets.